Culturing Practices and Antibiotic Use in Children with Diarrhea [8]

Pediatrics

Volumn 113, Issue 3 I, 2004, Pages 628-629

  Beatty, Mark E ^a,b,d   Griffin, Patricia M ^b   Tulu, Assefa N ^c   Olsen, Sonja J ^b,e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c Dallas Co Health and Human Services   (United States)

^d Division of Disease Control   (United States)

^e Intl Emerging Infections Program   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CAMPYLOBACTER; CHILD; DIARRHEA; DRUG USE; ESCHERICHIA COLI O157; FECES CULTURE; HUMAN; INFECTION CONTROL; LETTER; MAJOR CLINICAL STUDY; MEDICAL RECORD; PRESCRIPTION; PRIORITY JOURNAL; SALMONELLA; SHIGELLA; UNITED STATES; YERSINIA;

ANTI-BACTERIAL AGENTS; CHILD; DIARRHEA; EMERGENCY SERVICE, HOSPITAL; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FECES; HEMOLYTIC-UREMIC SYNDROME; HOSPITALS, PEDIATRIC; HUMANS; LABORATORIES, HOSPITAL; LABORATORY TECHNIQUES AND PROCEDURES;

EID: 1442274822     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.113.3.628     Document Type: Letter

References (10)

1. Mead PS, Griffin PM. Escherichia coli O157:H7. Lancet. 1998;352(9135):1207-1212
2. Voetsch AC, Rabatsky-Ehr T, Shallow S, et al. Stool specimen practices in clinical laboratories, FoodNet sites, 1995-2000. International Conference on Emerging Infectious Diseases. Atlanta, GA: Centers for Disease Control and Prevention; 2002:94
3. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157: H7 infections. N EngI J Med. 2000;342:1930-1936
4. Pavia AT, Nichols CR, Green DP, et al. Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations. J Pediatr. 1990;116:544-551
5. University outbreak of calicivirus infections mistakenly attributed to Shiga toxin-producing Escherichia coli O157:H7-Virginia, 2000. MMWR Morb Mortal Wkly Rep. 2001;50:489-491
6. Council of State and Territorial Epidemiologists. Position statements 2000 ID. Available at: www.cste.org/ps/2000/2000-id-04.htm. Accessed January 6, 2004
7. Sullivan MM, Besser J, Crouch N. High Incidence of Enterotoxigenic E. coli (ETEC) Isolated from stools among HMO patients with diarrhea in Minnesota. 100th General Meeting of the American Society for Microbiology. Washington, DC: American Society for Microbiology; 2000:683
8. Banatvala N, Giffin PM, Greene KD, et al. The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis. 2001;183:1062-1070
9. Bopp CA, Brenner FW, Fields PI, Wells JG, Strockbine NA. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, eds. Escherichia, Shigella, and Salmonella. Manual of Clinical Microbiology. 8th ed. Washington, DC: American Society for Microbiology Press; 2003;654-671
10. Molbak K, Mead PS, Griffin PM. Antimicrobial therapy in patients with Escherichia coli O157:H7 infection. JAMA. 2002;288:1014-1016